WTA World No. 2 Iga Swiatek changed her public relations representation after almost four years amid her doping controversy.

As 2024 comes to an end, former World No.1 Iga Swiatek has made another change to her team while dealing with the fallout of recent anti-doping violations.The five-time Grand Slam champion found

The five-time Grand Slam champion has served 22 days of a one-month ban from tennis. Here's what you need to know

Iga Swiatek is the second high-profile tennis player to test positive for a banned substance this year, joining Jannik Sinner. While Sinner, currently the No. 1 ranked man, was fully cleared, Swiatek,

The results for unspecified substances resulted in a mandatory provisional suspension, imposed on September 12th. This resulted in the Pole having to miss the WTA 500 in Korea (September 16-22), the WTA 1000 in Beijing (September 25-October 6) and the WTA 1000 in Wuhan (October 7-13).

Iga Swiatek, the women’s world No. 2 tennis player, has received a one-month doping ban after testing positive for the banned substance trimetazidine (TMZ).

The International Tennis Integrity Agency says five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine.

Meanwhile, Swiatek was found to have been “at the lowest end of the range for no significant fault or negligence” after the 23-year-old Polish player explained that her doping violation was caused by a contaminated supply of the non-prescription medication melatonin, which she uses to help with jet lag and sleep issues.

Iga Swiatek hopes to put the one-month doping ban behind her as quickly as possible, as she aims to get back on track in 2025.

Iga Swiatek's doping controversy refuses to die down. The post Tennis Controversy: Iga Swiatek’s Doping Drama Highlights Double Standards as Frustrated Insider Minces No Words appeared first on EssentiallySports.